v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Operating activities:      
Net loss $ (5,608,732) $ (4,530,058)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 21,303 20,660  
Stock-based compensation expense 403,509 419,504  
Other non-cash items 230,462 109,591  
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (278,213) (844,484)  
Long term deposit and other noncurrent assets (913) 927  
Accounts payable and other current liabilities 531,767 1,114,140  
Defined benefit pension plan (26,710) (23,176)  
Deferred grant income   (88,631)  
Total changes in operating assets and liabilities 225,931 158,776  
Cash used in operating activities (4,727,527) (3,821,527)  
Cash flow from financing activities:      
Net proceeds from issuance of shares in 2024 ATM Program (Note 13) 427,783 2,419,320  
Net proceeds from the exercise of warrants (Note 13) 2,063    
Payments of current portion of long-term debt (Note 11) (25,525) (22,242)  
Cash provided by financing activities 404,321 2,397,078  
Effect of exchange rate changes 24,589 109,535  
Net decrease in cash, cash equivalents and restricted cash (4,298,617) (1,314,914)  
Cash, cash equivalents and restricted cash at beginning of period 20,873,924 10,417,558 $ 10,417,558
Cash, cash equivalents and restricted cash at end of period $ 16,575,307 $ 9,102,644 $ 20,873,924